These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 21142859)

  • 21. Usefulness of transcription-reverse transcription concerted reaction method for detecting circulating tumor cells in patients with colorectal cancer.
    Sato N; Hayashi N; Imamura Y; Tanaka Y; Kinoshita K; Kurashige J; Saito S; Karashima R; Hirashima K; Nagai Y; Miyamoto Y; Iwatsuki M; Baba Y; Watanabe M; Baba H
    Ann Surg Oncol; 2012 Jun; 19(6):2060-5. PubMed ID: 21732137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of the circulating tumor cells in cancer patients.
    Armakolas A; Panteleakou Z; Nezos A; Tsouma A; Skondra M; Lembessis P; Pissimissis N; Koutsilieris M
    Future Oncol; 2010 Dec; 6(12):1849-56. PubMed ID: 21142859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
    Alunni-Fabbroni M; Sandri MT
    Methods; 2010 Apr; 50(4):289-97. PubMed ID: 20116432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical significance of circulating tumor cells in the peripheral blood.
    Elshimali YI; Grody WW
    Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
    Danova M; Torchio M; Mazzini G
    Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
    Ghossein RA; Carusone L; Bhattacharya S
    In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and Enumeration of Circulating Tumor Cells with Invasive Phenotype.
    Wang H; Wu X
    Adv Exp Med Biol; 2017; 994():133-141. PubMed ID: 28560672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.
    Paterlini-Bréchot P
    Future Oncol; 2011 Jul; 7(7):849-71. PubMed ID: 21732757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microfluidics and circulating tumor cells.
    Dong Y; Skelley AM; Merdek KD; Sprott KM; Jiang C; Pierceall WE; Lin J; Stocum M; Carney WP; Smirnov DA
    J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating tumor cells in lung cancer: detection methods and clinical applications.
    Yu N; Zhou J; Cui F; Tang X
    Lung; 2015 Apr; 193(2):157-71. PubMed ID: 25690734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.
    Ignatiadis M; Lee M; Jeffrey SS
    Clin Cancer Res; 2015 Nov; 21(21):4786-800. PubMed ID: 26527805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CTC clusters in cancer progression and metastasis.
    Fabisiewicz A; Grzybowska E
    Med Oncol; 2017 Jan; 34(1):12. PubMed ID: 28012133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Isolation of circulating tumor cells in blood by means of "Isolation by SizE of Tumor cells (ISET)"].
    Liadov VK; Skrypnikova MA; Popova OP
    Vopr Onkol; 2014; 60(5):548-52. PubMed ID: 25816657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highlighting the uniqueness in dielectrophoretic enrichment of circulating tumor cells.
    S Iliescu F; Sim WJ; Heidari H; P Poenar D; Miao J; Taylor HK; Iliescu C
    Electrophoresis; 2019 May; 40(10):1457-1477. PubMed ID: 30676660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival Mechanisms and Influence Factors of Circulating Tumor Cells.
    Wang WC; Zhang XF; Peng J; Li XF; Wang AL; Bie YQ; Shi LH; Lin MB; Zhang XF
    Biomed Res Int; 2018; 2018():6304701. PubMed ID: 30515411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in genomic characterization of circulating tumor cells.
    Magbanua MJ; Park JW
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):757-69. PubMed ID: 24867683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technical challenges in the isolation and analysis of circulating tumor cells.
    van der Toom EE; Verdone JE; Gorin MA; Pienta KJ
    Oncotarget; 2016 Sep; 7(38):62754-62766. PubMed ID: 27517159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor heterogeneity and circulating tumor cells.
    Zhang C; Guan Y; Sun Y; Ai D; Guo Q
    Cancer Lett; 2016 May; 374(2):216-23. PubMed ID: 26902424
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.